CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 287

Industry reads hand-picked by our editors

Sep 22, 2017

Reuters
Many drug companies fail to conduct timely safety checks on medicines after FDA approval
Kaiser Health News
High on drugs? Anthem cites soaring drug costs to justify 35% rate hike in California
MIT Technology Review
The easiest place to use CRISPR might be in your ear

Sep 21, 2017

Bloomberg
Cheer Alnylam's drug, pause on its platform
USA Today
CVS to limit opioid drug prescriptions amid national epidemic
Reuters
Africa to get state-of-art HIV drugs for $75 a year

Sep 20, 2017

Financial Times
Andrew Witty jumps into biotech venture capital sector
Phys.org
Technique could make it easier to use mRNA to treat disease or deliver vaccines
McClatchy DC
Attorneys general investigate role pharma companies played in opioid crisis

Sep 19, 2017

Politico
White House backs pharma partnership after delaying other opioid panel proposals
Xconomy
Disarm launches with $30M from Atlas, AbbVie to battle neuro disease
Clinical Leader
Is patient centricity just a buzzword?

Sep 18, 2017

NPR
Xanax or Zoloft for moms-to-be: A new study assesses safety
Financial Times
Clinigen and Quantum Pharma offer lesson to entrepreneurs
Reuters
Exclusive: FDA plans new compounding pharmacy policy, agency head says

Sep 15, 2017

Science
Pay up or retract? Drug survey spurs conflict
Reuters
Challenge of Allergan tribal patent deal in uncharted legal territory
Bloomberg Gadfly
Pharma keeps ignoring its price problem

Sep 14, 2017

Healthcare Dive
Senators offer polar opposite plans for changing healthcare system
Bloomberg
Japan's push to cut drug costs risks U.S. trade friction
Xconomy
BridgeBio bags $135M for “hub and spoke” rare disease drug R&D
Chicago Tribune
Insurers cutting back on drug coupons, saying it keeps consumer costs down

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Navigating the Impact of Claims Data Volatility on Biopharma Custom content for McKesson Compile
Infographic
Cutting Through the Chaos of Safety Letter Distribution Custom content for WCG
Playbook
How To Make the Most of Your Life Science Webinars Custom content for Cvent

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale
AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.